EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dissolution-permeation approach for biopharmaceutical evaluation: a feasibility study using naproxen

Andrejs Sitovs, Katarina Gurkina, Liga Petersone, Valentyn Mohylyuk

Journal of Pharmacy & Pharmaceutical Sciences · 11.05.2026 · 29

DOI: 10.3389/jpps.2026.16570 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmacy & Pharmaceutical Sciences, online erschienen am 11.05.2026. Verfasst von Andrejs Sitovs und 3 weiteren Autor:innen. Beteiligte Einrichtung: Leading Research Group, Faculty of Pharmacy, Rīga Stradiņš University, Riga, Latvia. Hauptthemen laut MEDLINE: Naproxen, Anti-Inflammatory Agents, Non-Steroidal. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Dissolution and/or release profile alone are insufficient to predict the in vivo absorption of poorly soluble drugs. Thus, permeation test becomes a critical component for biopharmaceutical assessment. Currently, none of the dissolution-permeation systems include the compendial dissolution, or provide large acceptor volumes, or are compatible with ex vivo membranes. Addressing the limitations of the existing dissolution-permeation testing systems, we propose the integration of the Ussing (permeability) chamber to the dissolution apparatus.

Methods

The assembled dissolution-permeation system evaluated the effect of 5% and 10% soy L-α-phosphatidylcholine in dodecane (LiDo) and permeable membrane material on apparent permeability coefficients of naproxen, a BCS II class drug.

Results

Naproxen release from the tablets reached approximately 100% within 30 min. Naproxen P app across a 0.45 µm PVDF membrane was 0.91 ± 0.35 × 10 -8 cm/s for 5% LiDo, and 0.75 ± 0.23 × 10 -8 cm/s for 10% LiDo. The 0.20 μm PC membrane with 5% LiDo showed a P app of 1.99 ± 0.57 × 10 -8 cm/s.

Conclusion

The proposed compendial dissolution-permeation system with an Ussing chamber allowed for the simultaneous determination of dissolution and permeability of naproxen. All P app values obtained were approximately 100-fold lower than those reported in the literature. The results may have been influenced by the differences in sink conditions and permeable membrane composition. The use of a PC membrane resulted in higher permeability, compared to the PVDF membrane. Adequately improved, this methodology could be transferred for the ex vivo membrane dissolution-permeability testing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NaproxenAnti-Inflammatory Agents, Non-SteroidalPermeabilitySolubilityFeasibility StudiesTabletsDrug LiberationMembranes, ArtificialPhosphatidylcholines

Stichwörter der Autor:innen

BCSdissolutionnaproxenpermeabilitypermeation

Substanzen

NaproxenTabletsAnti-Inflammatory Agents, Non-SteroidalMembranes, ArtificialPhosphatidylcholines

Autor:innen und Institutionen

  • Leading Research Group, Faculty of Pharmacy, Rīga Stradiņš University, Riga, Latvia.
  • Department of Pharmacology and Pharmacotherapy, Rīga Stradiņš University, Riga, Latvia.

Zitieren

APA

Sitovs, A., Gurkina, K., Petersone, L., & Mohylyuk, V. (2026). Dissolution-permeation approach for biopharmaceutical evaluation: a feasibility study using naproxen. Journal of Pharmacy & Pharmaceutical Sciences, 29. https://doi.org/10.3389/jpps.2026.16570

Vancouver

Sitovs A, Gurkina K, Petersone L, Mohylyuk V. Dissolution-permeation approach for biopharmaceutical evaluation: a feasibility study using naproxen. Journal of Pharmacy & Pharmaceutical Sciences. 2026;29. doi:10.3389/jpps.2026.16570

BibTeX
@article{Sitovs2026,
  author = {Sitovs, Andrejs and Gurkina, Katarina and Petersone, Liga and Mohylyuk, Valentyn},
  title = {Dissolution-permeation approach for biopharmaceutical evaluation: a feasibility study using naproxen},
  journal = {Journal of Pharmacy & Pharmaceutical Sciences},
  year = {2026},
  volume = {29},
  doi = {10.3389/jpps.2026.16570}
}
Kostenlos starten →